These class actions allege that the drug makers engaged in misleading marketing campaigns, failed to provide adequate warnings, and ignored growing concerns raised in medical literature and post-marketing surveillance about serious side effects, including gastrointestinal disorders, cyclic vomiting syndrome, and sudden vision loss
Burcham PC
While these medications are also effective for weight loss, Zepbounds additional mechanism of action through GIP may offer enhanced benefits for certain individuals
This study further strengthens the case for using GLP-1 agonists in obese patients with HFpEF, a type of heart failure that is associated with significant morbidity and mortality, said Pooja Prasad, MD, an assistant clinical professor in the Department of Advanced Heart Failure & Transplant Cardiology at the University of California San Francisco
More than medicationa complete transformation 2026 WeightLoss GLP-1 Program, VIP Health and Laser Clinic Gainesville, FL